← All indications
Drugs, Investigational
Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.
Drugs by status
Phase 4 trials (120)
- zidovudine
- thalidomide
- remifentanil
- insulin human
- simvastatin
- indobufen
- indocyanine green
- glimepiride
- naloxone
- parecoxib
- posaconazole
- glucosamine
- miglustat
- dexamethasone
- valsartan
- clopidogrel
- diacerein
- ubiquinone
- heparin
- sodium bicarbonate
- argatroban
- ketamine
- metronidazole
- midazolam
- sevoflurane
- alprazolam
- camrelizumab
- cilostazol
- porcine brain-derived peptide preparation
- ertugliflozin
- +90 more
Phase 3 trials (103)
- soybean
- favipiravir
- icotinib
- rilpivirine
- leuprolide
- cilastatin
- fosphenytoin
- ponatinib
- enoxaparin
- rivaroxaban
- apixaban
- pregabalin
- bevacizumab
- montelukast
- pyridoxine
- dasatinib
- leucovorin
- dolutegravir
- probiotic l9
- etoricoxib
- Iptacopan
- ritonavir
- dihydroartemisinin
- vinblastine
- hydroxyprogesterone
- levetiracetam
- denosumab
- prednisolone
- baclofen
- pegcetacoplan
- +73 more
Phase 2 trials (136)
- cyclophosphamide
- trifolium pratense
- Olverembatinib
- primidone
- carfilzomib
- tirofiban
- buprenorphine
- axitinib
- gd2 car t cells
- pasireotide
- envafolimab
- limertinib
- trastuzumab
- aldesleukin
- cyclosporine
- oteracil
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- sodium thiosulfate
- adebrelimab
- shr-a1904
- abiraterone
- alemtuzumab
- nivolumab
- mgd019
- fludarabine
- pyrotinib
- Befotertinib
- somatropin
- gnr-084
- gabapentin
- +106 more
Phase 1 trials (88)
- syd985
- dapagliflozin
- ethinyl estradiol
- diltiazem
- naproxen
- naloxegol
- butyrlcholinesterase, human (Recombinant)
- ipragliflozin
- allogeneic adipose derived mesenchymal stem cell
- darunavir
- hydronidone
- caffeine
- amino acids
- [111in]-fpi-1547
- sonidegib
- pexacerfont
- enzalutamide
- berberine
- gestodene
- autologous tumor infiltrating lymphocytes
- ketoconazole
- omega-3-carboxylic acids
- autologous cd19/cd22 chimeric antigen receptor t-cells
- tils and car-tils targeting her2, mesothelin, psca, muc1, lewis-y, gpc3, axl, egfr, claudin18.2/6, ror1, gd1, or b7-h3
- atomoxetine
- glutathione
- uk-396,082
- rifabutin
- verapamil
- tetrahydrocannabinol
- +58 more
Other trials (97)
- epicatechin
- mycophenolate
- indapamide
- bacillus coagulans
- astaxanthin
- vitamin c
- levodopa
- amlodipine
- bacillus subtilis
- glycerol
- pravastatin
- lactobacillus rhamnosus
- betamethasone
- nicotinamide
- leucine
- dezocine
- dipyridamole
- lopinavir
- potassium nitrate
- prasugrel
- temocillin
- 1,3-dimethylamylamine
- arginine silicate
- superstarch
- niacin
- radium-223
- lamotrigine
- autologous hematopoietic stem cells
- beta-aminoisobutyric acid
- hydroxychloroquine
- +67 more